Showing 2471-2480 of 2652 results for "".
- Zeiss and IDOC Partner to Bring Medical and Vision Care Products to Independent Optometrists Nationwidehttps://modernod.com/news/zeiss-and-idoc-partner-to-bring-medical-and-vision-care-products-to-independent-optometrists-nationwide/2476890/IDOC, Zeiss Vision Care US and Zeiss Medical Technology announced a 5-year agreement to bring Zeiss’ lab services, lens products and medical equipment to all 3,000+ IDOC independent optometrists across the United Stat
- PhysIOL to Launch FineVision Triumf Trifocal EDOF IOLhttps://modernod.com/news/physiol-to-launch-finevision-triumf-trifocal-edof-iol/2476879/BVI, through its PhysIOL subsidiary, announced the European launch of the FineVision Triumf EDOF trifocal presbyopia correcting IOL. Results from a year of clinical studies will be presented at the European Society for Cataract and Refractive Surgeons (ESCRS), held Septembe
- Oxurion Reports Additional Positive Topline Data from Phase 1 With THR-149, a Novel, Potent Plasma Kallikrein Inhibitor for DMEhttps://modernod.com/news/oxurion-reports-additional-positive-topline-data-from-phase-1-with-thr-149-a-novel-potent-plasma-kallikrein-inhibitor-for-dme/2476862/Oxurion reported additional positive topline data from a phase 1 study with THR-149, a novel, potent, plasma kallikrein (PKal) inhibitor for the treatment of diabetic macular edema (DME). This phase 1 open-label, multicenter (US), non-randomized trial evaluated the safety of a single intra
- Wills Eye Hospital Named #1 Ophthalmology Training Program In Americahttps://modernod.com/news/wills-eye-hospital-named-1-ophthalmology-training-program-in-america/2479536/Wills Eye Hospital has taken top honors again this year for the best residency training program in the United States for ophthalmologists. Doximity, which coordinates the vote, is the largest online physician network and is a navigator for medical students conside
- American Academy of Optometry Foundation Announces 2019 Fredric Rosemore Low Vision Educational Grant Recipienthttps://modernod.com/news/american-academy-of-optometry-foundation-announces-2019-fredric-rosemore-low-vision-educational-grant-recipient/2476860/The American Academy of Optometry Foundation (AAOF), in collaboration with the Fredric and Marion Rosemore Family Foundation, has announced that So-Yeon Sharon Lee, OD, FAAO, Dipl-ABO, was named the 2019 recipient of the Fredric Rosemore Low Vision Educational Grant. Dr. Lee is an Assistan
- NHS England to Fund Novartis’ Gene Therapy Luxturna for Inherited Retinal Diseasehttps://modernod.com/news/nhs-england-to-fund-novartis-gene-therapy-luxturna-for-inherited-retinal-disease/2476855/NHS England announced Wednesday funding for Novartis’ Luxturna (voretigene neparvovec) after agreeing a deal with the company that will provide access to the gene therapy from January 2020. The one-time treatment gained European Commission approval last year for patients with vision loss du
- Rayner Acquires Stake in Reper to Drive R&D and Build Presence in Russiahttps://modernod.com/news/rayner-acquires-stake-in-reper-to-drive-rd-and-build-presence-in-russia/2476854/Following a 4-year R&D collaboration on a novel hydrophobic IOL material, Rayner has acquired a stake in Reper, a material science and medical device company based in Russia. Terms of the deal were not disc
- Oxurion Completes Enrollment of Phase 1 Clinical Trial Evaluating THR-687 for the Treatment of DMEhttps://modernod.com/news/oxurion-completes-enrolment-of-phase-1-clinical-trial-evaluating-thr-687-for-the-treatment-of-dme/2476849/Oxurion NV announced the completion of enrollment of patients in a phase 1 trial with THR-687. The open-label, multicenter, dose escalation phase 1 study is evaluating the safety of a single intravitreal injection of escalating dose levels (3) of THR-687 for the treatment of patients with diabeti
- Santen Announces Topline Data for DE-128 (MicroShunt) Demonstrating Reductions in IOP and Medication Use in Patients With Glaucomahttps://modernod.com/news/santen-announces-topline-data-for-de-128-microshunt-demonstrating-reductions-in-iop-and-medication-use-in-patients-with-glaucoma/2476840/Santen Pharmaceutical announced the results of INN-005, a prospective, randomized, controlled, single-masked, multicenter study to assess the safety and effectiveness of DE-128 (MicroShunt) standalone, without concomitant cataract extraction. The study compared DE-128 implanted intraoperatively w
- The American Academy of Optometry Foundation Selects the 2019 Bert C. and Lydia M. Corwin Contact Lens Residency Award Recipienthttps://modernod.com/news/the-american-academy-of-optometry-foundation-selects-the-2019-bert-c-and-lydia-m-corwin-contact-lens-residency-award-recipient/2476831/The American Academy of Optometry has named Jocelyn Ou, OD, this year’s recipient of the Bert C. and Lydia M. Corwin Contact Lens Residency award. Dr. Ou is a cornea and contact lens resident at the Ketchum Health University Eye Center in Anaheim, California, and was ch